| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Flecainide | Flecainide EP Impurity A | VL1140001 | View |
| Flecainide | Flecainide EP Impurity B | VL1140002 | View CAS 22990-77-8 |
| Flecainide | Flecainide EP Impurity C | VL1140003 | View CAS 152171-74-9 |
| Flecainide | Flecainide EP Impurity D | VL1140004 | View CAS 35480-52-5 |
| Flecainide | Flecainide EP Impurity E | VL1140005 | View CAS 57415-36-8 |
| Catalogue No. | VL1140003 |
| CAS No. | 152171-74-9 |
| Molecular Formula | C17H20F6N2O4 |
| Molecular Weight | 430.35 |
| Parent drug | Flecainide |
| IUPAC Name | (RS)-4-hydroxy-N-(piperidin-2-ylmethyl)-2, 5-bis(2, 2, 2-trifluoroethoxy)benzamide |
| Synonyms | 4-Hydroxy Flecainide |
| References | “Sci-Hub, Flecainide a Preliminary Review of Its Pharmacodynamic Properties and Therapeutic Efficacy. Drugs, 29(1), 1–33, 10.2165/00003495-198529010-00001.” Sci-Hub.se, 2022, sci-hub.se/link.springer.com/article/10.2165/00003495-198529010-00001. |
| Status | In-stock |
| ListName | Flecainide EP Impurity C |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
